Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis

Preexisting autoimmune disease affects between 10% and 30% of patients with myelodysplastic syndromes (MDS). Studies comparing outcomes in patients with MDS with and without autoimmune disease show discordant results. Using the Surveillance, Epidemiology, and End Results Medicare database, we conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrianzen-Herrera, Diego, Sparks, Andrew D., Singh, Rohit, Alejos-Castillo, David, Batra, Akshee, Glushakow-Smith, Shira, Pradhan, Kith, Shastri, Aditi, Zakai, Neil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685168/
https://www.ncbi.nlm.nih.gov/pubmed/37729616
http://dx.doi.org/10.1182/bloodadvances.2023011050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685168/
https://www.ncbi.nlm.nih.gov/pubmed/37729616
http://dx.doi.org/10.1182/bloodadvances.2023011050

Ejemplares similares